US IDE trial finds embolization “safe and efficacious” for benign prostatic hyperplasia

A prospective US FDA-approved investigational device exemption (IDE) study has demonstrated significant improvement in lower urinary tract symptoms secondary to benign prostatic hyperplasia and...

New augmented reality system lets IRs “literally see through the patient”

European Radiology Experimental has recently published a study on a new augmented reality system that is able to accurately guide interventional oncology procedures. A three-step...

ABK Biomedical appoints Michael J Mangano as president and CEO

ABK Biomedical, a company dedicated to the research, development and commercialisation of innovative embolic therapies, has announced the appointment of Michael J Mangano as...

US FDA grants Breakthrough Therapy Designation for combination immunotherapy in HCC treatment

Roche has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for Tecentriq (atezolizumab) in combination with Avastin (bevacizumab)...

Alex Tang


Laura Findeiss

Gerard Goh

(Visited 3,057 times, 1 visits today)